Skip to content
Menu

CRISPR Therapeutics AG CRSP

Full chart Compare
Set alert

Price alert · CRSP

All alert types
40.19 USD +0.04 (+0.10%)

Regular-session close

40.98 +0.79 +1.98%

After hours · Nov 18, 4:10 PM ET

40.10 Day range 42.66
39.80 52-week range 63.45
YTD
-23.36%
1 year
-24.84%

Revenue & Expenses

Revenue Profit Costs
Net Loss$581.60MCost of Revenue$232.96MExpenses$581.60MGross Loss$229.45MSelling, General & Admin$73.54MResearch & Development$265.33MOther Expenses$9.65MIncome Tax$3.63MRevenue$3.51M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CRSP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.51M37.31M371.21M1.20M914.96M
3.51M37.31M371.21M1.20M914.96M
-664.57M-466.57M-222.54M-673.16M373.53M
-581.60M-366.25M-153.61M-650.17M377.66M
-6.47-4.34-1.94-8.364.70
CRSP annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
355.19M309.78M401.07M223.52M939.94M
2.27B2.24B2.23B2.24B2.75B
343.43M309.95M346.77M367.58M352.42M
206.75M223.69M238.63M244.02M225.03M
1.92B1.93B1.88B1.88B2.40B
CRSP annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-345.01M-142.77M-260.38M-495.74M538.97M
-31.80M-280.48M374.65M-258.65M-1.04B
426.03M331.98M62.66M38.59M250.94M
-914.00K-1.90M-9.47M-37.19M-81.70M
49.30M-91.29M177.01M-715.88M-245.52M